Dennis Polk SNX Plan Sales Hit Hyve Spotlight

Dennis Polk, the TD SYNNEX director and Chair of Hyve Solutions, sold 2,500 shares of SNX on June 15 for roughly $711,000, according to a Form 4 filed after the market close on June 16. The filing matters less because it is a surprise trade and more because it lands at the exact intersection of two live TD SYNNEX stories: a record fiscal 2026 start for the distributor and a newly formalized executive role for Polk inside Hyve, the company's data-center and accelerated-compute operation.

The transaction was not presented as a fresh, discretionary bearish call. The Form 4, accession 0001177394-26-000064, marks the sales with transaction code S and states that they were made under a Rule 10b5-1 trading plan adopted on January 16, 2026 by Polk on behalf of the Polk Family Trust. That footnote changes the framing. This is a scheduled sale by a long-running insider, not a sudden exit signal after a stock move.

The full ownership picture also cuts against overreaction. The June Form 4 shows 76,647 shares held by trust after the sale and a separate direct non-derivative holding of 22,439 shares. There was no derivative Table II position on this filing, and Polk was not flagged as a 10% owner. A separate 13D/G scan for TD SYNNEX showed outside beneficial owners such as FMR, company-affiliated 13G records, and passive holders, but not a Dennis Polk beneficial-ownership match. The correct read is narrower: a prearranged trust sale by an executive chair who still reported a meaningful Form 4 share position.

The sale: three prints, one prearranged plan

The June filing breaks Polk's sale into three non-derivative common-stock transactions, all on June 15. The Polk Family Trust sold 510 shares at a weighted average price of $283.80, 1,790 shares at $284.40, and 200 shares at $285.07. Together, the trade covered 2,500 shares for about $711,000. The SEC footnotes specify that the $283.80 and $284.40 prices were weighted averages across multiple executions, with the underlying ranges available to the SEC staff or security holders on request.

That June print continued a visible 2026 cadence. The same insider record shows 2,500 shares sold on May 15 for roughly $576,000, 2,500 shares sold on April 17 for about $527,000, and a January exercise-and-sell sequence that followed option exercises. Across the platform record, Polk's Form 4 history shows roughly $95.2 million of lifetime reported sale value tied to TD SYNNEX, Concentrix, and Terreno Realty filings. For the news event in front of investors now, though, the cleanest number is the latest $711,000 SNX sale under the January 2026 plan.

That distinction is important because code S alone can be misleading. Code S means an open-market sale, but the Form 4's 10b5-1 flag means the plan was already in place before the June execution. Investors can still care about the pace, price level, and remaining stake, but the filing does not support a claim that Polk woke up on June 15 and made a new judgment call on TD SYNNEX's near-term prospects.

Why Polk's role makes this more than a transaction log

Polk is not just another director selling into strength. In May, TD SYNNEX filed an updated offer letter stating that he would continue as Chair, Hyve Solutions Holdings, reporting solely to CEO Patrick Zammit, while remaining on the board. The agreement set a $840,000 annual base salary, a target annual incentive bonus at 100% of salary, and about $1.5 million in annual equity awards split between time-based restricted stock and performance-based RSUs.

Hyve is the reason the timing has an external narrative. TD SYNNEX's fiscal 2026 first quarter, reported on March 31, showed revenue of $17.2 billion, up 18.1% year over year, and non-GAAP gross billings of $25.8 billion, up 24.4%. Management described strength across distribution and Hyve, and the company's release said Hyve designs, manufactures, and delivers traditional and accelerated compute, cloud, and connected infrastructure worldwide. In plain English: the business Polk chairs is plugged into the AI server and data-center hardware cycle that has been reshaping the IT channel.

The channel backdrop was not vague. On the Q1 call, management highlighted PC refresh demand, AI-enabled servers, infrastructure, security, software, and improving networking demand. Channel Dive separately reported that rising memory and storage component prices lifted first-quarter results, with management saying demand remained strong even as hardware costs rose. That gives the Form 4 a real hook: a long-tenured executive chair is selling planned shares while the part of TD SYNNEX closest to hyperscale and AI infrastructure is receiving more investor attention.

That hook should not be stretched into a bearish verdict. If anything, the record points to a governance and timing story. Polk's updated employment terms formalized his Hyve role effective December 1, 2025; the sale plan was adopted January 16, 2026; TD SYNNEX reported a strong fiscal Q1 on March 31; and the June sale executed months later at prices above the April and May plan-sale prints in the same data set.

Ownership check: what the filing does and does not say

The first ownership trap is to look only at the final transaction line and treat it as a full-position read. Here, the latest transaction line shows 76,647 shares remaining by trust after the last June sale. The same Form 4 also includes a direct non-derivative holding of 22,439 shares. Because the derivative table was empty, there is no separate option or Class B holding to add from Table II on this filing. Because the post-sale balance was not zero, there is no exit framing to make.

The second trap is to confuse Polk's insider position with the broader institutional holder base. The current TD SYNNEX stock page shows 631 current institutional holders in the platform data. The largest current reported holders include BlackRock, Fidelity parent FMR, Vanguard Portfolio Management, Vanguard Capital Management, Brave Warrior Advisors, and Abrams Bison Investments. Some of those holders are passive index managers; their presence is market exposure, not an insider-motive signal.

Active-manager ownership still matters for context. Brave Warrior's reported SNX position was about 12.75% of its disclosed 13F portfolio at the Q1 2026 report date, while Abrams Bison's reported SNX position was about 18.20% of its portfolio. Those are portfolio-concentration data points, not confirmations of Polk's motive. They tell investors that the stock has a concentrated holder audience watching the same AI infrastructure, PC refresh, and component-pricing setup.

How to read the next Form 4 from Polk

The actionable checkpoint is not whether one more planned sale appears. The June filing already tells readers that the January 16 plan is active. The better question is whether the cadence changes. April, May, and June each show 2,500-share SNX sales. If future Form 4s keep that same monthly rhythm, the data supports systematic plan execution. If the size or structure changes, the comparison should start with the plan footnotes and the remaining Form 4 holdings before drawing any conclusion.

The price context is also useful. April's reported sale was at $210.70, May's weighted-average prices were about $229.74 to $231.26, and June's sale cleared at roughly $283.80 to $285.07. That is a large step-up in execution prices over two months. For an event-driven reader, the story is not simply "insider sells." It is that Polk's insider profile is now showing scheduled sales at much higher SNX prices while TD SYNNEX is telling investors that distribution, Hyve, AI-enabled servers, and B2B PC refresh are all part of the 2026 setup.

There is one more ownership reason to stay precise. The 13D/G file set for TD SYNNEX includes external institutions and company-affiliated records, but it does not turn Polk into a 5% filer. So the fair sentence is not that a controlling owner is reducing control. It is that a director and Hyve executive chair sold trust-held common stock under a disclosed 10b5-1 plan while still reporting direct and trust-held non-derivative shares on Form 4.

FAQ

Why is Dennis Polk selling SNX stock?

Dennis Polk's latest SNX sales were reported under a Rule 10b5-1 trading plan adopted on January 16, 2026, so the Form 4 points to scheduled selling rather than a newly timed discretionary trade.

How much SNX did Dennis Polk sell in June 2026?

Polk sold 2,500 TD SYNNEX shares on June 15, 2026, for roughly $711,000 across three weighted-average sale prices between about $283.80 and $285.07.

How many SNX shares did Dennis Polk report after the sale?

The June Form 4 showed 76,647 shares held by trust after the reported transactions and a separate direct non-derivative holding of 22,439 shares.

What makes the Dennis Polk Form 4 newsworthy for TD SYNNEX investors?

The filing lands after TD SYNNEX reported record fiscal 2026 first-quarter results and formalized Polk's Hyve Solutions leadership role, tying a planned insider sale to a company-specific AI infrastructure narrative.